Breakthrough in Cancer Treatment: Researchers Develop Degradable Metal-Nanomedicine for Enhanced Chemodynamic Therapy

Strategic Insights -

Researchers from Central South University have made a significant breakthrough in cancer treatment by developing a degradable metal-small molecule drug coordination nanomedicine that enhances chemodynamic therapy (CDT) effects for lung cancer treatment. This innovative approach targets the DNA damage repair system, providing a new avenue for cancer treatment. Funded by the National Natural Science Foundation of China and the Department of Science and Technology of Hunan Province, the study demonstrates the therapeutic efficacy of this nanomedicine against A549 lung cancer in mice with minimal systemic toxicity.

Key Takeaways:

  • The researchers developed a degradable metal-small molecule drug coordination nanomedicine (siAPE1/Cu-MP@HA) that targets DNA damage repair for enhanced CDT effects in cancer treatment.
  • The nanomedicine is designed for specific releases of Cu, siAPE1, and 6-MP in tumor cells due to weak acidity/glutathione (GSH) dual-responsiveness.
  • The siAPE1/Cu-MP@HA promotes the generation of hydroxyl radicals (OH) from endogenous H2O2 via Fenton-like reaction, significantly enhancing the CDT anticancer effect.
  • The in vivo experiments demonstrated the remarkable therapeutic efficacy of the siAPE1/Cu-MP@HA against A549 lung cancer in mice with minimal systemic toxicity after intravenous administration.
  • The researchers concluded that the study offers an innovative approach targeting the DNA damage repair system for enhancing CDT effects in cancer treatment.

Statistics:

  • The siAPE1/Cu-MP@HA nanomedicine is designed for the specific release of Cu, siAPE1, and 6-MP in tumor cells.
  • The in vivo experiments demonstrated a significant enhancement of CDT anticancer effect in mice treated with the siAPE1/Cu-MP@HA at a dose of 20 mg/kg.
  • The therapeutic efficacy of the siAPE1/Cu-MP@HA was demonstrated in A549 lung cancer in mice with minimal systemic toxicity after intravenous administration.

Sources:

  • Degradable Metal-Small Molecule Drug Coordination Nanomedicines for DNA Damage-Augmented Cancer Chemodynamic Therapy. Small, 2025.
  • NewsRx. Central South University Reports Findings in Cancer (Degradable Metal-Small Molecule Drug Coordination Nanomedicines for DNA Damage-Augmented Cancer Chemodynamic Therapy). Nanotechnology Weekly. May 19, 2025; p 58.